CRL licensing and community input features are only available with a CRL member login.
If your institution is a CRL Member please:
log in or sign upCRL licensing and community input features are only available with a CRL member login.
If your institution is a CRL Member please:
log in or sign upBiomedical research and clinical practice with a special focus on all aspects of drug discovery and development. Embase provides users with timely access to pharmacological and biomedical literature to keep them up to date with the latest scientific developments. It contains records from over 7,000 journals from over 70 countries, which are fully indexed. Over 18 million bibliographic records are included with over 2,000 new records being added each working day.
Since 2002 EMBASE has had a cover-to-cover policy: all articles (apart from book reviews and obituaries) are covered.
Before 2002 this policy applied to most titles (>90%), but some were covered selectively for drugs information only.
Gaps due to missing issues are actively filled: missing issues are claimed from journals publishers and added to the database as soon as they are received.
Not filled are:
- gaps due to journals not being covered from vol 1 iss 1.
- gaps that occur for a few journals which were not covered during a certain period of their existence.
We do not aim to cover all journals back to vol 1 iss 1.
For many journals, coverage was begun when they had already been in existence for some years. In such cases the back years are not indexed.
Embase.com currently delivers full text links to ScienceDirect, Karger Online Journals and Springer-Link. Articles from more than 100 additional publishers are available through CrossRef. Further links are offered through 'Ingenta Select'.
Users can select search options that best matches their requirements; they can choose from: search forms, quick search, advanced search, field search, drug search, disease search and article search.
It is also possible to conduct mapped searches in Emtree on synonyms and preferred terms simultaneously.
Usage statistics will be provided by email on a monthly basis in html/excel format. The statistics are not COUNTER compliant.
Access is via Athens, IP address range, and username and password.